Read the latest news and updates from NCATS. Is this email not displaying correctly?
View it in your browser.

NCATS | Collaborate. Innovate. Accelerate.

Volume 11 │ Issue 1 │ January 19, 2022

Director’s Message
Director's Message

In her first message of 2022, NCATS Acting Director Dr. Joni Rutter shares her vision for the decade ahead and how NCATS will continue to strive to develop more treatments for all people more quickly.

Read More


What's Happening
Exploring the Progress and Potential of the Tox21 10K Chemical Library
Predicting Future Infectious Influenza Disease Variants with Lung Tissue Chips Rare Diseases and the Promise of Gene Therapy

Announcements & Opportunities
HEAL Target and Compound Library, Request Access Now Enroll in Online MEDI502 Translational Science Course, Class Begins Jan. 31, 2022
Participate in an Assay Guidance Workshop, Save the Date for Feb. 5, 2022 Attend Virtual Rare Disease Day at NIH, Join Us Feb. 28, 2022
Funding Opportunities Collaborate with NCATS Scientists

Meet NCATS Staff
Christopher M. Hartshorn, Ph.D.

Christopher M. Hartshorn, Ph.D.
is the chief of the Digital & Mobile Technologies Section within NCATS’ Division of Clinical Innovation.

 Abir N. Malik, M.S.

Abir N. Malik, M.S.
is a scientific program analyst in NCATS’ Office of Drug Development Partnership Programs.

Learn more about these and other staff members >

Contact Us

National Center for Advancing Translational Sciences
National Institutes of Health
6701 Democracy Boulevard, 9th Floor
Bethesda, MD 20892

For language access assistance, contact the NCATS Public Information Officer.

To view previous newsletters, click here.
Share Share
Tweet Tweet
Forward Forward
NIH






This email was sent to akeller@scgcorp.com
why did I get this?    unsubscribe from this list    update subscription preferences
National Center for Advancing Translational Sciences · National Institutes of Health · 6701 Democracy Boulevard, 9th Floor · Bethesda, MD 20892 · USA